Immunohistochemical analysis of paraffin-embedded human placenta tissue using p14 ARF antibody.

CDKN2A Antibody

Vendor: CUSABIO

Type: Antibodies

SKU: CSB-PA288756-100ul

Explore specifications & documents
$297.00 USD
Shipping calculated at checkout.

Available in stock (500)

View UniProt Entry
Request a quotation
  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.
Immunohistochemical analysis of paraffin-embedded human placenta tissue using p14 ARF antibody.

CDKN2A Antibody

$297.00 USD

THE SCIENCE, IN DETAIL

Know your product.

Specifications
Alternative names
CDKN2A antibody; CDKN2 antibody; MLM antibody; Tumor suppressor ARF antibody; Alternative reading frame antibody; ARF antibody; Cyclin-dependent kinase inhibitor 2A antibody; p14ARF antibody
Antigen
Synthesized peptide derived from Human p14 ARF antibody.
Buffer
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Clonality
Polyclonal
Clone number
N/A
Conjugated
Non-conjugated
Form
liquid
Host species
Rabbit
Isotype
IgG
Purification method
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Research area
Cell Biology
Species
Human
Species reactivity
Human
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target name
CDKN2A
Tested applications
ELISA, WB, IHC, IF; WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500
Uniprot id
Q8N726
Scientific background
Target: CDKN2A. Antigen: Synthesized peptide derived from Human p14 ARF antibody.. Reactivity: Human. Applications: ELISA, WB, IHC, IF; WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500. Polyclonal I...

A PARTNER IN YOUR RESEARCH

More time for discovery. Less time sourcing.

Bring your laboratory requirements together with scientific advice, global sourcing and dedicated procurement support.

Explore our services

Starting a new laboratory?

Plan your laboratory with our New-Lab programme.

Discover New-Lab